Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction - A combined analysis from multicenter trials

Clinical Cardiology

Volumn 28, Issue 10, 2005, Pages 471-478

  Yap, Yee Guan ^a   Duong, Trinh ^a   Bland, J Martin ^a   Malik, Marek ^a   Torp Pedersen, Christian ^b   Køber, Lars ^c   Connolly, Stuart J ^d   Marchant, Bradley ^e   Camm, A John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d MCMASTER UNIVERSITY   (Canada)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Acute myocardial infarction; All cause mortality; Arrhythmic mortality; Cardiac mortality; Demographic

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE; FIBRINOLYTIC AGENT; PLACEBO; SOTALOL; TRANDOLAPRIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DISEASE COURSE; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOMES RESEARCH; PREDICTION; PROBABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 26444495001     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960281006     Document Type: Article

References (31)

1. Kaduskar S, Bradshaw H, Rayner M: Coronary Heart Disease Statistics, p. 9. British Heart Foundation Statistics Database, 1997
2. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD: Short- and long-term prognosis of acute myocardial infarction since introduction of thrombolysis. B Med J 1993;307:349-353
3. Norris RM, Gaughey DE, Deeming LW, Mercer CJ, Scott PJ: Coronary prognostic index for predicting survival after recovery from acute myocardial infarction. Lancet 1970;ii:485-487
4. Julian D, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, for the European Myocardial Infarct Amiodarone Trial Investigators: Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-674
5. Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial investigators: Randomised trial outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 1997;349:675-682
6. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil D, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP, for the SWORD investigators: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators: Survival With Oral d-Sotalol. Lancet 1996;348:7-12
7. Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole D, Auclert L, Pauly N, Aliot E, Persson S, Camm AJ, for the TRAndolapril Cardiac Evaluation (TRACE) Study Group: A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333(25):1670-1676
8. The DIAMOND Study Group: Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patients characteristics of the DIAMOND studies. Clin Cardiol 1997:20:704-710
9. Marcus FI, Cobb LA, Edwards JE, Kuller L, Moss AJ, Bigger JT, Fleiss JL, Polnitzky L, Serokman R, and the Multicenter Post Infarction Research Group: Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after myocardial infarction. Am J Cardiol 1988; 61:8-15
10. Lee KL, Woodlief LH, Topol EJ, Weaver D, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM, for the GUSTO-I Investigators: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Circulation 1995;91:1659-1668
11. White HD, Barbash GI, Modan M, Simes J, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EAC, Van der Werf T, Pehrsson K, Sandøe E, Wilcox RG, Verstraete M, von der Lippe G, Van de Werf F; for the Investigators of the International Tissue Plasminogen Activator/ Streptokinase Mortality Study: After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation 1993;88:2097-2103
12. Lincoff AM, Califf RM, Ellis SG, Sigmon KN, Lee KL, Leimberger JD, Topol EJ: Thrombolytic therapy for women with myocardial infarction: Is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1993;22:1780-1787
13. Malacrida R, Genoni M, Maggioni AP, Spataro V, Parish S, Palmer A, Collins R, Moccetti T: A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med 1998;338:8-14
14. Vaccarino V, Parsons L, Every NR, Barron UV, Krumholz HM, for the National Registry of myocardial infarction 2 Participants: Sex-biased differences in early mortality after myocardial infarction. N Engl J Med 1999;341: 217-225
15. Greene HL: Sudden arrhythmic cardiac death-mechanisms, resuscitation and classification: The Seattle perspective. Am J Cardiol 1990;65:4B-12B
16. Sweeney MO, Moss AJ, Eberly S: Instantaneous cardiac death in the posthospital period after acute myocardial infarction. Am J Cardiol 1992;70: 1375-1379
17. Larsen JA, Radish AH: Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol 1998;9:655-664
18. McHugh NA, Cook SM, Schauer JL, Bidgoli MM, Merrill GF: Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: Effects of estrogen. Am J Physiol 1995;268:H2569-2573
19. Kim YD, Chen B, Beauregard J, Kouretes P, Thomas G, Farhat MY, Myers AK, Lees DE: 17 beta-estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation 1996;94:2901-2908
20. Wannamethee G, Shaper AG, Macfarlane PW, Walker M: Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995;91: 1749-1756
21. Wellens HJ: Sudden death late after a myocardial infarction: Substrate and risk stratification. In Sudden Cardiac Death. Prevalence, Mechanism, and Approaches to Diagnosis and Management (Eds. Akhtar M, Myerburg RJ, Ruskin JN), pp. 147-154. Malvern: Williams and Wilkins, 1994
22. Spargias K, Ball S, Hall A: The prognostic significance of a history of systemic hypertension in patients randomised to either placebo or ramipril following acute myocardial infarction: Evidence from the AIRE study. J Hum Hypertens 1999;13:511-516
23. Josephson RA, Chahine RA, Morganroth J, Anderson J, Waldo A, Hallstrom A, for the CAST Investigators: Prediction of cardiac death in patients with a very low ejection fraction after myocardial infarction: A cardiac arrhythmia suppression trial (CAST) study. Am Heart J 1995;130:685-691
24. Pedretti RF, Catalano O, Ballardini L, de Bono DP, Radice E, Tramarin R: Prognosis in myocardial infarction survivors with left ventricular dysfunction is predicted by electrocardiographic RR interval but not QT dispersion. Int J Cardiol 1999;68:83-93
25. Schwartz PJ, La Rovere MT, Vanoli E: Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992;85(suppl I):177-91
26. Gheorghiade M, Schultz L, Tilley B, Kao W, Goldstein S: Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial. Am Heart J 1991;112:1548-1553
27. Benhorin J, Moss AJ, Oakes D, Marcus F, Greenberg H, Dwyer EM Jr, Algeo S, Hahn E: The prognostic significance of first myocardial infarction type (Q wave versus non-Q wave) and Q-wave location. J Am Coll Cardiol 1990;15:1201-1207
28. Berger CJ, Murabito JM, Evans JC, Anderson KM, Levy D: Prognosis after first myocardial infarction. Comparison of Q wave and non-Q wave myocardial infarction in the Framingham Heart Study. J Am Med Assoc 1992; 268:1545-1551
29. Goodman SG, Langer A, Ros AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, Armstrong PW: Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: Angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators. Circulation 1998;97:444-450
30. Matetzky S, Barabash GI, Rabinowitz B, Rath S, Zahav YH, Agranat O, Kaplinsky E, Hod H: Q wave and non-Q wave myocardial infarction after thrombolysis. J Am Coll Cardiol 1995;26:1445-1451
31. Greene HL: Clinical significance and management of arrhythmias in the heart failure patient. Clin Cardiol 1992;15(suppl I):I13-21